# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-002893
Filing Date
2025-01-13
Accepted
2025-01-13 09:00:18
Documents
41
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm253125d1_8k.htm iXBRL | 8-K | 32713
2 | EXHIBIT 99.1 | tm253125d1_ex99-1.htm | EX-99.1 | 41111
6 | GRAPHIC | tm253125d1_ex99-1img01.jpg | GRAPHIC | 94874
7 | GRAPHIC | tm253125d1_ex99-1img02.jpg | GRAPHIC | 376267
8 | GRAPHIC | tm253125d1_ex99-1img03.jpg | GRAPHIC | 205495
9 | GRAPHIC | tm253125d1_ex99-1img04.jpg | GRAPHIC | 220598
10 | GRAPHIC | tm253125d1_ex99-1img05.jpg | GRAPHIC | 179216
11 | GRAPHIC | tm253125d1_ex99-1img06.jpg | GRAPHIC | 172175
12 | GRAPHIC | tm253125d1_ex99-1img07.jpg | GRAPHIC | 225848
13 | GRAPHIC | tm253125d1_ex99-1img08.jpg | GRAPHIC | 276290
14 | GRAPHIC | tm253125d1_ex99-1img09.jpg | GRAPHIC | 67497
15 | GRAPHIC | tm253125d1_ex99-1img10.jpg | GRAPHIC | 253684
16 | GRAPHIC | tm253125d1_ex99-1img11.jpg | GRAPHIC | 217507
17 | GRAPHIC | tm253125d1_ex99-1img12.jpg | GRAPHIC | 209653
18 | GRAPHIC | tm253125d1_ex99-1img13.jpg | GRAPHIC | 243413
19 | GRAPHIC | tm253125d1_ex99-1img14.jpg | GRAPHIC | 235617
20 | GRAPHIC | tm253125d1_ex99-1img15.jpg | GRAPHIC | 275353
21 | GRAPHIC | tm253125d1_ex99-1img16.jpg | GRAPHIC | 186501
22 | GRAPHIC | tm253125d1_ex99-1img17.jpg | GRAPHIC | 253368
23 | GRAPHIC | tm253125d1_ex99-1img18.jpg | GRAPHIC | 228759
24 | GRAPHIC | tm253125d1_ex99-1img19.jpg | GRAPHIC | 218833
25 | GRAPHIC | tm253125d1_ex99-1img20.jpg | GRAPHIC | 73857
26 | GRAPHIC | tm253125d1_ex99-1img21.jpg | GRAPHIC | 207771
27 | GRAPHIC | tm253125d1_ex99-1img22.jpg | GRAPHIC | 265604
28 | GRAPHIC | tm253125d1_ex99-1img23.jpg | GRAPHIC | 56903
29 | GRAPHIC | tm253125d1_ex99-1img24.jpg | GRAPHIC | 163979
30 | GRAPHIC | tm253125d1_ex99-1img25.jpg | GRAPHIC | 182807
31 | GRAPHIC | tm253125d1_ex99-1img26.jpg | GRAPHIC | 133327
32 | GRAPHIC | tm253125d1_ex99-1img27.jpg | GRAPHIC | 80994
| Complete submission text file | 0001104659-25-002893.txt |  | 7575094

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | glyc-20250113.xsd | EX-101.SCH | 3030
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | glyc-20250113_lab.xml | EX-101.LAB | 34240
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | glyc-20250113_pre.xml | EX-101.PRE | 22369
43 | EXTRACTED XBRL INSTANCE DOCUMENT | tm253125d1_8k_htm.xml | XML | 3555

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 25525040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)